ESTRELLA IMMUNOPHARMA, INC. (ESLAW) Capital expenditures
ESTRELLA IMMUNOPHARMA, INC. (ESLAW) annual capital expenditure history — cash spent on property, plant and equipment, per SEC filings.
No annual history for this metric yet
The company may have no SEC filings (ETF / non-US listing), or the concept is absent from its filings.
← Back to ESLAWSource: SEC XBRL filings · For reference only · Not investment advice
More ESLAW financial trends
ESLAW RevenueESLAW Net incomeESLAW Net marginESLAW Gross profitESLAW Gross marginESLAW Operating incomeESLAW Operating marginESLAW Operating cash flowESLAW Free cash flowESLAW Return on equityESLAW Stock buybacksESLAW Dividends paidESLAW Total assetsESLAW Total liabilitiesESLAW Shareholders’ equityESLAW overview →